EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Tumor budding and the prognosis of patients with metastatic colorectal cancer: a meta-analysis

Qiao Qu, Di Wu, Zhilong Li, Hongzhuan Yin

International Journal of Colorectal Disease · 24.05.2023 · 38 (1)

DOI: 10.1007/s00384-023-04423-8 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Colorectal Disease, online erschienen am 24.05.2023. Verfasst von Qiao Qu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shengjing Hospital of China Medical University, No.36, Sanhao Street, Heping District, Shenyang, 110000, Liaoning Prov…. Hauptthemen laut MEDLINE: Colonic Neoplasms, Rectal Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Tumor budding has been suggested to be associated with poor survival of patients with colorectal cancer (CRC). However, it is unclear whether the association remains in patients with metastatic CRC (mCRC). The aim of the systematic review and meta-analysis was to investigate the potential predictive role of tumor budding for the prognosis of patients with mCRC. METHODS: PubMed, Embase, Cochrane Library, and Web of Science were searched for relevant observational studies comparing the survival outcomes between mCRC patients with high versus low tumor budding. Data collection, literature searching, and statistical analysis were conducted independently by two authors. Using a heterogeneity-incorporating random-effects model, the results were pooled. RESULTS: In this meta-analysis, 1503 patients from nine retrospective cohort studies were included. Pooled results showed that compared to those with low tumor budding, mCRC patients with high tumor budding were associated with a poor progression-free survival (hazard ratio (HR), 1.65; 95% confidence interval (CI), 1.31 to 2.07, p 0.05). CONCLUSION: A high-degree tumor budding may be associated with poor prognosis in patients with mCRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsRectal NeoplasmsHumansRetrospective StudiesPrognosisData Collection

Stichwörter der Autor:innen

Meta-analysisMetastatic colorectal cancerProgressionSurvivalTumor budding

Autor:innen und Institutionen

  • Department of General Surgery, Shengjing Hospital of China Medical University, No.36, Sanhao Street, Heping District, Shenyang, 110000, Liaoning Province, China.
  • Department of General Surgery, Shengjing Hospital of China Medical University, No.36, Sanhao Street, Heping District, Shenyang, 110000, Liaoning Province, China. hzyin_863@21cn.com.

Zitieren

APA

Qu, Q., Wu, D., Li, Z., & Yin, H. (2023). Tumor budding and the prognosis of patients with metastatic colorectal cancer: a meta-analysis. International Journal of Colorectal Disease, 38(1). https://doi.org/10.1007/s00384-023-04423-8

Vancouver

Qu Q, Wu D, Li Z, Yin H. Tumor budding and the prognosis of patients with metastatic colorectal cancer: a meta-analysis. International Journal of Colorectal Disease. 2023;38(1). doi:10.1007/s00384-023-04423-8

BibTeX
@article{Qu2023,
  author = {Qu, Qiao and Wu, Di and Li, Zhilong and Yin, Hongzhuan},
  title = {Tumor budding and the prognosis of patients with metastatic colorectal cancer: a meta-analysis},
  journal = {International Journal of Colorectal Disease},
  year = {2023},
  volume = {38},
  number = {1},
  doi = {10.1007/s00384-023-04423-8}
}
Kostenlos starten →